Cushing disease: Morbidity and mortality analysis associated with patients of Centro Médico Docente la Trinidad
DOI:
https://doi.org/10.55361/cmdlt.v15iSuplemento.123Keywords:
Cushing disease, Hypercortisolism, Severe CushingAbstract
Summary: Cushing disease is the main cause of neoplastic endogenous hypercortisolism. Of the tumor registry of the Centro Médico Docente La Trinidad consultation, we analyzed the morbimortality. Methods and Materials: it's an observational, descriptive, retrospective, cross- sectional study. Twelve patients diagnosed with Cushing's disease between 2017-2020. Results: the majority of patietns were female with an average age of 35,75±10,17, The most frequent discriminative clinical characteristics were easy bruising, violaceous striae, depression and facial plethora, of the non-discriminative ones the most frequent were hirsutism, female baldness, weight gain/obesity and dorsocervical hump. About the diagnosis there was an increase of >36 μg/dl of serum cortisol in 40% qualifying as Severe Cushing; 40% had 24 hour urinary free cortisol 4 times the upper normal value (UNV), 30% between 1.5 and 2.7 times the UNV; 83,33% suppressed with the dexamethasone test, 5 patients had ACTH values between 6-76 pg/ml and four >76pg/mL, 82% were microadenomas and 75% were seen in surgery and at macroscopic analysis in pathology report. Transsphenoidal surgery) was performed in 66,66%, complications were CSF fistula, 25% permanent diabetes insipidus and 25% had intraoperative hemorrhage. Cushing's Disease recurrence was observed in 41,6%, persistence in 33,33%, clinically significant partial improvement in 25%, complete remission in 25% and death in 1/12 patients due to diabetes insipidus.Conclusions: initial severe presentation of Cushing’s disease is usual, early treatment could reduce the level of severity that the patients with Cushing's disease develop to prevent complications.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista Científica CMDLT

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



